Best practice in precision medicine for prostate cancer
Prof Raez speaks to ecancer at BEST OF ASCO® 2018 MIAMI SYMPOSIUM about immunotherapy related studies for lung cancer.
He describes the results, potential changes to practice, drawbacks of each study for squamous and non squamous lung cancer.
Best practice in precision medicine for prostate cancer
Key insights from lung cancer research at ASCO 2025
ELCC 2025: Latest in EGFR positive NSCLC
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
ESMO 2024: Latest in EGFR mutated NSCLC
ESMO 2024: Optimising the personalisation of prostate cancer treatment
ASCO 2024: Lung cancer highlights
EAU 2024: Bladder cancer latest
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus